Abstract: Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder.
Type:
Grant
Filed:
March 5, 2024
Date of Patent:
August 18, 2026
Assignee:
Albert Einstein College of Medicine
Inventors:
Evripidis Gavathiotis, Richard N. Kitsis, Thomas Peter Garner, Dulguun Amgalan, Lorrie Kirshenbaum, Felix Kopp